APOC2 and hypertriglyceridemia: Novel homozygous apolipoprotein C2 (APOC2)-ablated golden Syrian hamster that exhibits severe hypertriglyceridemia was established with CRISPR/Cas9, and the genetically modified hamster is useful to study the APOC2 function and its effect on lipid and glucose homeostasis [137].